https://scitechdaily.com/double-trouble-for-cancer-tumors-the-dual-action-immunotherapy-breakthrough/
0
0
10/4/23 at 3:13pm
Organization
SciTechDaily
Authors
The small molecule, now in clinical trials, increases activity of immune cells and sensitivity of tumors to immune attack. Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients eith…
Create an account
or login to join the discussion